Algert Global LLC Global Blood Therapeutics, Inc. Transaction History

Algert Global LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	SELL	$32.4 - $68.18 $596,419 - $1.26 Million	-18,408 Reduced 46.25%	21,393 $1.46 Million
Q2 2022 Aug 15, 2022	BUY	$22.3 - $37.39 $316,726 - $531,050	14,203 Added 55.48%	39,801 $1.27 Million
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $318,765 - $441,778	12,413 Added 94.14%	25,598 $887,000
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $328,306 - $530,828	13,185 New	13,185 $386,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.